Hyaluronic%25252525252525252525252525252525252525252525252525252525252525252525252520acid

# Hyaluronic Acid ## Overview Hyaluronic acid is a naturally occurring polysaccharide found in various tissues, including the skin, joints, and eyes. It acts as a lubricant and shock absorber. Pharmaceutical preparations are typically derived from bacterial fermentation or animal sources. ## Primary Indications * **Intra-articular injection:** Osteoarthritis of the knee (pain relief). * **Ophthalmic solution:** Dry eye disease (lubrication). * **Dermal filler:** Aesthetic correction of wrinkles and folds. * **Surgical aid:** Viscosupplementation in ophthalmic surgery. ## Adult Dosing * **Osteoarthritis of the knee:** Typically 20 mg (2 mL of 1% solution) injected intra-articularly once weekly for 3 weeks. Some protocols may involve 5 injections. Maximum frequency is usually every 6 months. * **Dry eye disease:** Ophthalmic solutions vary widely by brand. Common concentrations range from 0.1% to 0.4%. Instill 1 drop into the affected eye(s) as needed, often 1-4 times daily. Some formulations are available as single-use vials or multi-dose bottles. * **Dermal filler:** Varies by product and treatment area. Administered by trained professionals. * **Ophthalmic surgery:** Varies by surgical procedure and product. Administered by ophthalmologists. ## Pediatric Dosing Established pediatric dosing for intra-articular hyaluronic acid for osteoarthritis is generally not available. Use in children for ophthalmic indications (dry eye) is generally safe based on product labeling, but specific dose adjustments are not typically required beyond standard use as an artificial tear. ## Dose Adjustments * **Renal/Hepatic Impairment:** No specific dose adjustments are typically required as systemic absorption is minimal for topical or intra-articular formulations. ## Contraindications * Known hypersensitivity to hyaluronic acid or any component of the formulation. * Active infection at or near the injection site for intra-articular use. * Skin infection at or near the injection site for dermal filler use. ## Adverse Effects * **Intra-articular:** Localized pain, swelling, stiffness, itching, warmth at the injection site. * **Ophthalmic:** Transient blurred vision, eye irritation, stinging, redness. * **Dermal filler:** Bruising, swelling, redness, itching, pain, infection, nodules, allergic reactions. ## Key Drug Interactions * **Intra-articular:** Concurrent use of topical antiseptics containing quaternary ammonium salts may cause precipitation of hyaluronic acid. Avoid using other intra-articular injections concurrently unless clinically indicated. * **Ophthalmic:** May potentially reduce the absorption of other topical ophthalmic medications. Separate administration by at least 5 minutes. ## Monitoring * **Intra-articular:** Monitor for signs of infection or inflammatory reactions post-injection. Assess pain relief and functional improvement. * **Ophthalmic:** Monitor for symptom relief of dry eye. Assess for ocular irritation or adverse reactions. ## Clinical Pearls * For intra-articular use, avoid strenuous weight-bearing activities or prolonged standing for 24-48 hours post-injection. * Different brands and concentrations exist for ophthalmic use; consult product labeling for specific recommendations. * Dermal filler and surgical uses require administration by qualified healthcare professionals. * Hyaluronic acid is generally well-tolerated but allergic reactions can occur. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and product labeling for complete details. Dosing and indications may vary based on specific product formulations and local protocols.